In today’s Trish Regan Show, Trish breaks down the newest poll numbers that are leaving …
Read More »Alzheimer’s experimental drug may slow progression of disease, but there are risks: experts
The experimental drug lecanemab has indicated a slowing of cognitive decline progression by 27% in patients with early-stage Alzheimerās, according to a study published this week in the New England Journal of Medicine. “These findings show that lecanemab offers promise for people with early Alzheimerās disease, with a significant slowing …
Read More »